Bucchi L, Giudici F, Toffolutti F, De Paoli A, Mancini S, Preti M, Gatta G, Ferretti S, Crocetti E, Fiore AR, Bidoli E, Caldarella A, Falcini F,...
Prevalence
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030
Guzzinati S, Toffolutti F, Francisci S, De Paoli A, Giudici F, De Angelis R, Demuru E, Botta L, Tavilla A, Gatta G, Capocaccia R, Zorzi M, Caldarella A, Bidoli E, Falcini F, Bruni R, Migliore E, Puppo A, Ferrante M, Gasparotti C, Gambino ML, Carrozzi G, Bianconi F, Musolino A, Cavallo R, Mazzucco W, Fusco M, Ballotari P, Sampietro G, Ferretti S, Mangone L, Mantovani W, Mian M, Cascone G, Manzoni F, Galasso R, Piras D, Pesce MT, Bella F, Seghini P, Fanetti AC, Pinna P, Serraino D, Rossi S, Dal Maso L; AIRTUM Working Group. ESMO Open. 2024 Jul;9(7):103635. doi: 10.1016/j.esmoop.2024.103635. Epub 2024 Jul 23.
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, Zorzi M, Fusco M, Caldarella A, Rossi S, De Angelis R, Botta L, Ravaioli A,...
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R,...
Projecting cancer prevalence by phase of care: a methodological approach for health service planning
Francisci S, Tursini F, Dal Maso L, Gigli A, Guzzinati S. Front Oncol. 2023 Aug 30;13:1201464. doi: 10.3389/fonc.2023.1201464. eCollection 2023....
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
Toffolutti F, Guzzinati S, De Paoli A, Francisci S, De Angelis R, Crocetti E, Botta L, Rossi S, Mallone S, Zorzi M, Manneschi G, Bidoli E, Ravaioli...
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Front...
Cancer cost profiles: The Epicost estimation approach
Francisci S, Capodaglio G, Gigli A, Mollica C, Guzzinati S. Front Public Health. 2022 Sep 21;10:974505. doi: 10.3389/fpubh.2022.974505. eCollection...
Cancer prevalence by phase of care: an indicator for assessing health service needs
Gigli A, Francisci S, Guzzinati S, Hall A, Hachey M, Scoppa S, Mariotto A. Tumori. 2020 Oct 23:300891620961839. doi: 10.1177/0300891620961839....
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project
Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG. Cancer Epidemiol. 2013 Dec;37(6):850-6. doi:...